Results 201 to 210 of about 143,538 (238)

SPARCL1 and NT‐proBNP as biomarkers of right ventricular‐to‐pulmonary artery uncoupling in pulmonary hypertension

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1416-1426, April 2025.
Abstract Aims SPARCL1 was recently identified as a biomarker of right ventricular (RV) maladaptation in patients with pulmonary hypertension (PH), and N‐terminal pro‐brain natriuretic protein (NT‐proBNP) is an established biomarker of RV failure in PH. The present study investigated whether NT‐proBNP and SPARCL1 concentrations are associated with load ...
Oliver Dörr   +15 more
wiley   +1 more source

Coronary calcium score in patients with post-surgical hypoparathyroidism. [PDF]

open access: yesArch Endocrinol Metab
de Souza Sartori JF   +5 more
europepmc   +1 more source

Coronary calcium score and emphysema extent on different CT radiation dose protocols in lung cancer screening. [PDF]

open access: yesEur Radiol
Ledda RE   +10 more
europepmc   +1 more source

Effects of Combining Coronary Calcium Score With Treatment on Plaque Progression in Familial Coronary Artery Disease: A Randomized Clinical Trial.

open access: yesJAMA
Nerlekar N   +14 more
europepmc   +1 more source

Comparative Prognostic Value of Coronary Calcium Score and Perivascular Fat Attenuation Index in Coronary Artery Disease. [PDF]

open access: yesJ Clin Med
Savo MT   +15 more
europepmc   +1 more source

In the search of coronary calcium

International Journal of Cardiology, 2013
The recognition of coronary artery calcium (CAC) as an indicator of coronary artery disease for more than 30 years has created a great interest in methods for its accurate assessment. In this review we present the imaging techniques capable of detecting CAC and discuss their current status in clinical practice. The first non-invasive CAC imaging method
Dimitrios, Alexopoulos   +1 more
openaire   +2 more sources

Coronary Calcium Scanning

The American Heart Hospital Journal, 2006
While there is no doubt that high-risk patients (those with more than a 20% 10-year risk of a future cardiovascular event) need more aggressive preventive therapy, a majority of cardiovascular events occur in individuals at intermediate risk (10%-20% 10-year risk).
Ambarish, Gopal, Matthew J, Budoff
openaire   +2 more sources

Home - About - Disclaimer - Privacy